Juventas Therapeutics Garners $5,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=265c44d9-512a-4b7b-ba95-de255b8c7bce
Date
11/21/2013
Company Name
Juventas Therapeutics
Mailing Address
3615 Superior Avenue Cleveland, OH 44114
Company Description
Juventas Therapeutics is a privately held biotechnology company developing a pipeline of regenerative therapies to treat life–threatening diseases. The company’s lead product, Stromal–cell Derived Factor 1 (SDF–1), has been shown to protect and repair tissue following organ–damage in a broad range of pre–clinical disease models.
Website
http://www.Juventasinc.com
Transaction Type
Venture Equity
Transaction Amount
$5,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed